Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetyl cysteine in women with endometrioma undergoing IVF/ICSI
IRCT20210619051619N1Phase 3Completed
- Sponsor
- Royan Institute
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in endometrioma and endometriosis comparing N-acetylcysteine with Placebo (2 arms). Primary endpoint: MII oocyte number and quality. Started Apr 2021; status: completed.
02
Drugs
acetylcysteine
03
Conditions
endometriomaendometriosis
Beyond the preview
Go deeper on IRCT20210619051619N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210619051619N1.